z-logo
Premium
Letter: mesalazine—a safe drug with rare serious adverse events
Author(s) -
Scrivo Barbara,
Renna Sara,
Casà Angelo,
Monachino Noemi,
Macaluso Fabio S.,
Orlando Ambrogio
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15691
Subject(s) - medicine , mesalazine , drug , adverse effect , pharmacology , ulcerative colitis , disease

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom